Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Trial of G-CSF Stimulated Bone Marrow vs. Conventional Bone Marrow as a Stem Cell Source In Matched Sibling Donor Transplantation

NCT00450450 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00450450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Trial of G-CSF Stimulated Bone Marrow vs. Conventional Bone Marrow as a Stem Cell Source In Matched Sibling Donor Transplantation
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
March 31, 2022
Enrollment
27 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute lymphoblastic leukemia in remission, childhood acute myeloid leukemia in remission, childhood chronic myelogenous leukemia, childhood myelodysplastic syndromes, chronic phase chronic myelogenous leukemia, de novo myelodysplastic syndromes, juvenile myelomonocytic leukemia, previously treated myelodysplastic syndromes, recurrent childhood acute lymphoblastic leukemia, secondary myelodysplastic syndromes